Clinical Research Directory
Browse clinical research sites, groups, and studies.
Subcutaneous Calcitonin in Acute Herpes Zoster
Sponsor: Tanta University
Summary
This prospective randomized controlled study will be conducted to evaluate the effect of adding calcitonin to the standard treatment protocol in patients with acute herpes zoster infection.
Official title: The Prophylactic Value of Subcutaneous Calcitonin in Acute Herpes Zoster Patients: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
168
Start Date
2026-07-01
Completion Date
2027-10-01
Last Updated
2026-06-18
Healthy Volunteers
No
Interventions
Calcitonin
patients will receive subcutaneous salmon calcitonin 100 IU (ampoule = 1 ml) daily for three weeks
Saline
patients will receive subcutaneous saline (1 ml) daily for three weeks.
Locations (1)
Tanta University Hospitals
Tanta, Gharbia Governorate, Egypt